Occurrence and removals of micropollutants in water environment

  • Kim, Moon-Kyung (Department of Environmental Health Sciences, School of Public Health, Seoul National University) ;
  • Zoh, Kyung-Duk (Department of Environmental Health Sciences, School of Public Health, Seoul National University)
  • Received : 2016.09.21
  • Accepted : 2016.11.28
  • Published : 2016.12.30


Micropollutants are often discharged to surface waters through untreated wastewater from sewage treatment plants and wastewater treatment plants. The presence of micropollutants in surface waters is a serious concern because surface water is usually provided to water treatment plants (WTP) to produce drinking water. Many micropollutants can withstand conventional WTP systems and stay in tap water. In particular, pharmaceuticals and endocrine disruptors are examples of micropollutants that are detected at the drinking water, ppb, or even ppb level. A variety of techniques and processes, especially advanced oxidation processes, have been applied to remove micropollutants from water to control drinking water contamination. This paper reviews recent researches on the occurrence and removal of micropollutants in the aquatic environments and during water treatment processes.


Supported by : National Research Foundation of Korea (NRF)


  1. Lapworth DJ, Baran N, Stuart ME, Ward RS. Emerging organic contaminants in groundwater: A review of sources, fate and occurrence. Environ. Pollut. 2012;163:287-303.
  2. Verlicchi P, Al Aukidy M, Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment-a review. Sci. Total Environ. 2012;429:123-155.
  3. Thomas PM, Foster GD. Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process. Environ. Toxicol. Chem. 2005;24:25-30.
  4. Poulsen PB, Jensen AA, Wallstrom E. More environmentally friendly alternatives to PFOS-compounds and PFOA. Environmental Project no.10132005. 2005.
  5. Prevedouros K, Cousins IT, Buck RC, Korzeniowski SH. Sources, fate and transport of perfluorocarboxylates. Environ. Sci. Technol. 2006;40:32-44.
  6. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics and antagonists. J. Steroid Biochem. Mol. Biol. 1998;65:143-150.
  7. Ellis JB. Pharmaceutical and personal care products (PPCPs) in urban receiving waters. Environ. Pollut. 2006;144:184-189.
  8. Caliman FA, Gavrilescu M. Pharmaceuticals, personal care products and endocrine disrupting agents in the environment-A review. CLEAN-Soil, Air, Water 2009;37:277-303.
  9. Monteiro SC, Boxall ABA. Occurrence and fate of human pharmaceuticals in the environment. Rev. Environ. Contam. T. 2010;202:53-154.
  10. Zhou J, Zhang Z, Banks E, Grover D, Jiang JQ. Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water. J. Hazard. Mater. 2009;166: 655-661.
  11. Grujic S, Vasiljevic T, Lausevic M. Determination of multiple pharmaceutical classes in surface and ground waters by liquid chromatography-ion trap-tandem mass spectrometry. J. Chromatogr. A. 2009;1216:4989-5000.
  12. Choi K, Kim Y, Park J, et al. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci. Total Environ. 2008;405:120-128.
  13. Barnes KK, Kolpin DW, Furlong ET, Zaugg SD, Meyer MT, Barber LB. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States-I) Groundwater. Sci. Total Environ. 2008;402:192-200.
  14. Boyd GR, Reemtsma H, Grimm DA, Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ. 2003;311:135-149.
  15. Snyder SA, Westerhoff P, Yoon Y, Sedlak DL. Pharmaceuticals, personal care products, and endocrine disruptors in water: implications for the water industry. Environ. Eng. Sci. 2003 ;20:449-469.
  16. Chen M, Ohman K, Metcalfe C, Ikonomou MG, Amatya PL, Wilson J. Pharmaceuticals and endocrine disruptors in wastewater treatment effluents and in the water supply system of Calgary, Alberta, Canada. Water Qual. Res. J. Can. 2006;41:351-364.
  17. Kim SD, Cho J, Kim IS, Vanderford BJ, Snyder SA. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007;41:1013-1021.
  18. Kumar A, Chang B, Xagoraraki I. Human health risk assessment of pharmaceuticals in water: issues and challenges ahead. Int. J. Environ. Res. Public Health. 2010;7:3929-3953.
  19. Wille K, Noppe H, Verheyden K, et al. Validation and application of an LC-MS/MS method for the simultaneous quantification of 13 pharmaceuticals in seawater. Anal. Bioanal. Chem. 2010;397:1797-1808.
  20. Capdeville MJ, Budzinski H. Trace-level analysis of organic contaminants in drinking waters and groundwaters. TrAC-Trend. Anal. Chem. 2011;30:586-606.
  21. Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson AK, Reissman DB. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 2004;329: 99-113.
  22. Kim SC, Carlson K. Quantification of human and veterinary antibiotics in water and sediment using SPE/LC/MS/MS. Anal. Bioanal. Chem. 2007;387:1301-1315.
  23. Huerta-Fontela M, Galceran MT, Ventura F. Occurrence and removal of pharmaceuticals and hormones through drinking water treatment. Water Res. 2011;45:1432-1442.
  24. EU, 2008. European Union. Water framework directive 2008/105/EC. European parliament and of the council. [cited 20 August 2016]. Available from: legal-content/EN/TXT/?uri=CELEX:32008L0105.
  25. Canadian Environmental Protection Act, 1999. [cited 20 August 2016]. Available from:
  26. Deblonde T, Cossu-Leguille C, Hartemann P. Emerging pollutants in wastewater: A review of the literature. Int. J. Hyg. Environ. Health. 2011;214:442-448.
  27. Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H. Removal of selected pharmaceuticals, fragrances an endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005;39: 4797-4807.
  28. International Environment Forum: Micropollutants. [cited 20 August 2016]. Available from:
  29. Metz DH, Meyer M, Dotson A, Beerendonk E, Dionysiou DD. The effect of UV/$H_2O_2$ treatment on disinfection by-product formation potential under simulated distribution system conditions. Water Res. 2011;45:3969-3980.
  30. Shah AD, Krasner SW, Lee CFT, von Gunten U, Mitch WA. Trade-offs in disinfection byproduct formation associated with precursor preoxidation for control of N-nitrosodimethylamine formation. Environ. Sci. Technol. 2012;46:4809-4818.
  31. Chu W, Gao N, Yin D, Krasner SW, Mitch WA. Impact of UV/$H_2O_2$ pre-oxidation on the formation of haloacetamids and other nitrogenous disinfection byproducts during chlorination. Environ. Sci. Technol. 2014;48:12190-12198.
  32. Bila D, Montalvao AF, Azevedo DA, Dezotti M. Estrogenic activity removal of 17$\beta$-estradiol by ozonation and identification of by-products. Chemosphere 2007;69:736-714.
  33. Maniero MG, Bila DM, Dezotti M. Degradation and estrogenic activity removal of 17$\beta$-estradiol and 17$\alpha$-ethinylestradiol by ozonation and $O_3/H_2O_2$. Sci. Total. Environ. 2008;407:105-115.
  34. Sun Q, Deng S, Huang J, Yu G. Relationship between oxidation products and estrogenic activity during ozonation of 4-nonylphenol. Ozone Sci. Eng. 2008;30:120-126.
  35. Altmann J, Ruhl AS, Zietzschmann F, Jekel M. Direct comparison of ozonation and adsorption onto powdered activated carbon for micropollutant removal in advanced wastewater treatment. Water Res. 2014;55:185-193.
  36. Lee Y, von Gunten U. Oxidative transformation of micropollutants during municipal wastewater treatment: comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrate(VI), and ozone) and non-selective oxidants (hydroxyl radical). Water Res. 2010;44:555-566.
  37. Wert EC, Rosario-Ortiz FL, Drury DD, Snyder SA. Formation of oxidation byproducts from ozonation of wastewater. Water Res. 2007;41:1481-1490.
  38. Wert EC, Rosario-Ortiz FL, Snyder SA. Effect of ozone exposure on the oxidation of trace organic contaminants in wastewater. Water Res. 2009;43:1005-1014.
  39. Pereira RO, de Alda ML, Joglar J, Daniel LA, Bardelo D. Identification of new ozonation disinfection byproducts of 17$\beta$-estradiol and estrone in water. Chemosphere 2011;84: 1535-1541.
  40. Richardson SD, Thruston Jr AD, Caughran TV, Chen PH, Collette TW, Floyd TL. Identification of new ozone disinfection byproducts in drinking water. Environ. Sci. Technol. 1999;33:3368-3377.
  41. Schmidt CK, Brauch HJ. N,N-Dimethylsulfamide as precursor for N-Nitrosodimethylamine (NDMA) formation upon ozonation and its fate during drinking water treatment. Environ. Sci. Technol. 2008;42:6340-6346.
  42. Zhao YY, Boyd JM, Woodbeck M, et al. Formation of N-nitrosamines from eleven disinfection treatments of seven different surface waters. Environ. Sci. Technol. 2008;42:4857-4862.
  43. Sarathy SR, Mohseni M. The impact of UV/$H_2O_2$ advanced oxidation on molecular size distribution of chromophoric natural organic matter. Environ. Sci. Technol. 2007;41:8315-8320.
  44. Jo CH, Dietrich AM, Tanko JM. Simultaneous degradation of disinfection byproducts and earthy-musty odorants by the UV/$H_2O_2$ advanced oxidation process. Water Res. 2011;45: 2507-2516.
  45. Bazri MM, Barbeau B, Mohseni M. Impact of UV/$H_2O_2$ advanced oxidation treatment on molecular weight distribution of NOM and biostability of water. Water Res. 2012;46:5297-5304.
  46. Dotson AD, Keen VS, Metz D, Linden KG. UV/$H_2O_2$ treatment of drinking water increases post-chlorination DBP formation. Water Res. 2010;44:3703-3713.
  47. Kosjek T, Heath E. Applications of mass spectrometry to identifying pharmaceutical transformation products in water treatment. TrAC-Trend. Anal. Chem. 2008;27:807-820.
  48. American Chemistry Council, 2008. The benefits of chlorine chemistry in water treatment.$File/ATT4WSEA.pdf.
  49. Pinkston KE, Sedlak DL. Transformation of aromatic ether-and amine containing pharmaceuticals during chlorine disinfection. Environ. Sci. Technol. 2004;38:4019-4025.
  50. Sim WJ, Lee JW, Oh JE. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ. Pollut. 2010;158:1938-1947.
  51. Christman RF, Norwood DL, Millington DS, Johnson JD, Stevens AA. Identity and yields of major halogenated products of aquatic fulvic acid chlorination. Environ. Sci. Technol. 1983;17:625-628.
  52. Oliver BG. Dihaloacetonitriles in drinking water: Algae and fulvic acid as precursors. Environ. Sci. Technol. 1983;17:80-83.
  53. von Gunten U. Ozonation of drinking water: Part I. Oxidation kinetics and product formation. Water Res. 2003;37:1443-1467
  54. von Gunten U. Ozonation of drinking water: Part II. Disinfection and by-product formation in presence of bromide, iodide or chlorine. Water Res. 2003;37:1469-1487.
  55. Sojic D, Despotovic V, Orcic D, et al. Degradation of thiamethoxam and metoprolol by UV, O$_3$, and UV/O$_3$ hybrid processes: Kinetics, degradation intermediates and toxicity. J. Hydrol. 2012;472-473:314-327.
  56. Rivas F, Gimeno O, Borralho T, Carbajo M. UV-C radiation based methods for aqueous metoprolol elimination. J. Hazard. Mater. 2010;179:357-362.
  57. Jin J, El-Din MG, Bolton JR. Assessment of the UV/Chlorine process as an advanced oxidation process. Water Res. 2011;45:1890-1896.
  58. Nam SW, Yoon Y, Choi DJ, Zoh KD. Degradation characteristics of metoprolol during UV/chlorination reaction and a factorial design optimization. J. Hazard. Mater. 2015;285:453-463.
  59. Vilve M, Hirvonen A, Sillanpaa M. Ozone-based advanced oxidation processes in nuclear laundry water treatment. Environ. Technol. 2007;28:961-968.
  60. Sui Q, Huang J, Deng S, Yu G, Fan Q. Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res. 2010;44:417-426.
  61. Gerrity D, Gamage S, Holady JC, et al. Pilot-scale evaluation of ozone and biological activated carbon for trace organic contaminant mitigation and disinfection. Water Res. 2011;45: 2155-2165.
  62. Kim JW, Jang HS, Kim JG, et al. Occurrence of pharmaceutical and personal care products (PPCPs) in surface water from Mankyung River, South Korea. J. Health Sci. 2009;55:249-258.
  63. Huber MM, Ternes TA, von Gunten U. Removal of estrogenic activity and formation of oxidation products during ozonation of 17$\alpha$-ethinylestradiol. Environ. Sci. Technol. 2004;38:5177-5186.
  64. Luo Y, Guo W, Ngo HH, et al. A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Sci. Total Environ. 2014;473-474:619-641.
  65. Thuy PT, Moons K, Van Dijk J, Viet Anh N, Van der Bruggen B. To what extent are pesticides removed from surface water during coagulation-flocculation? Water Environ. J. 2008;22: 217-223.
  66. Adams C, Wang Y, Loftin K, Meyer M. Removal of antibiotics from surface and distilled water in conventional water treatment processes. J. Environ. Eng. 2002;128:253-260.
  67. Stumm W, Morgan JJ, Drever JI. Aquatic Chemistry: Chemical equilibria and rates in natural waters. 3rd ed. New York: Wiley Interscience; 1996. p. 519-521.
  68. Kovalova L, Siegrist H, von Gunten U, Eugster J, Hagenbuch M, Wittmer A. Elimination of micropollutants during post-treatment of hospital wastewater with powdered activated carbon, ozone, and UV. Environ. Sci. Technol. 2013;47: 7899-7908.
  69. Hernandez-Leal L, Temmink H, Zeeman G, Buisman C. Removal of micropollutants from aerobically treated grey water via ozone and activated carbon. Water Res. 2011;45: 2887-2896.
  70. Snyder SA, Adham S, Redding AM, et al. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 2007;202:156-181.
  71. Grover D, Zhou J, Frickers P, Readman J. Improved removal of estrogenic and pharmaceutical compounds in sewage effluent by full scale granular activated carbon: Impact on receiving river water. J. Hazard. Mater. 2011;185:1005-1011.
  72. Yang X, Flowers RC, Weinberg HS, Singer PC. Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant. Water Res. 2011;45:5218-5228.
  73. Rossner A, Snyder SA, Knappe DR. Removal of emerging contaminants of concern by alternative adsorbents. Water Res. 2009;43:3787-3796.
  74. Bolong N, Ismail AF, Salim MR, Matsuura T. A review of the effects of emerging contaminants in wastewater and options for their removal. Desalination 2009;239:229-246.
  75. Korich D, Mead J, Madore M, Sinclair N, Sterling CR. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability. Appl. Environ. Microbiol. 1990;56:1423-1428.
  76. Asano T, Levine AD. Wastewater reclamation, recycling and reuse: Past, present, and future. Water Sci. Technol. 1996;33:1-14.
  77. Richardson SD. Disinfection by-products and other emerging contaminants in drinking water. TrAC-Trend. Anal. Chem. 2003;22:666-684.
  78. Gallard H, von Gunten U. Chlorination of phenols: Kinetics and formation of chloroform. Environ. Sci. Technol. 2002;36: 884-890.
  79. Westerhoff P, Yoon Y, Snyder S, Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 2005;39:6649-6663.
  80. Rodriguez-Mozaz S, Lopez de Alda MJ, Barcelo D. Monitoring of estrogens, pesticides and bisphenol A in natural waters and drinking water treatment plants by solid-phase extraction-liquid chromatography-mass spectrometry. J. Chromatogr. A. 2004;1045:85-92.
  81. Stackelberg PE, Gibs J, Furlong ET, Meyer MT, Zaugg SD, Lippincott RL. Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci. Total Environ. 2007;377:255-272.
  82. Boleda MR, Galceran MT, Ventura F. Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ. Pollut. 2011;159:1584-1591.
  83. Vieno NM, Harkki H, Tuhkanen T, Kronberg L. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 2007;41:5077-5084.
  84. Gregory J, Duan J. Hydrolyzing metal salts as coagulants. Pure Appl. Chem. 2001;73:2017-2026.
  85. Duan J, Gregory J. Coagulation by hydrolysing metal salts. Adv. Colloid Interface Sci. 2003;100-102:475-502.
  86. Matilainen A, Vepsalainen M, Sillanpaa M. Natural organic matter removal by coagulation during drinking water treatment: A review. Adv. Colloid Interface Sci. 2010;159:189-197.
  87. Nam SW, Choi DJ, Kim SK, Her N, Zoh KD. Adsorption characteristics of selected hydrophilic and hydrophobic micropollutants in water using activated carbon. J. Hazard. Mater. 2014;270:144-152.
  88. Ozacar M, Sengil IA. Evaluation of tannin biopolymer as a coagulant aid for coagulation of colloidal particles. Colloid. Surface. A. 2003;229:85-96.
  89. Wang JP, Chen YZ, Ge XW, Yu HQ. Optimization of coagulation/flocculation process for a paper-recycling wastewater treatment using response surface methodology. Colloid. Surface. A. 2007;302:204-210.
  90. Ye C, Wang D, Shi B, Yu J, Qu J, Edwards M, Tang H. Alkalinity effect of coagulation with polyaluminum chlorides: Role of electrostatic patch. Colloid. Surface. A. 2007;294:163-173.
  91. Matamoros V, Salvado V. Evaluation of a coagulation/flocculation-lamellar clarifier and filtration-UV-chlorination reactor for removing emerging contaminants at full-scale wastewater treatment plants in Spain. J. Environ. Manage. 2013;117:96-102.
  92. Suarez S, Lema JM, Omil F. Pre-treatment of hospital wastewater by coagulation-flocculation and flotation. Bioresour. Technol. 2009;100:2138-2146.
  93. Asakura H, Matsuto T. Experimental study of behavior of endocrine-disrupting chemicals in leachate treatment process and evaluation of removal efficiency. Waste Manage. 2009;29:1852-1859.
  94. Choi KJ, Kim SG, Kim SH. Removal of antibiotics by coagulation and granular activated carbon filtration. J. Hazard. Mater. 2008;151:38-43.
  95. Kuster M, Lopez de Alda MJ, Hernando MD, Petrovic M, Martin-Alonso J, Barcelo D. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J. Hydrol. 2008;358;112-123.
  96. Kumar KS, Priya SM, Peck AM, Sajwan KS. Mass loadings of triclosan and triclocarbon from four wastewater treatment plants to three rivers and landfill in Savannah, Georgia, USA. Arch. Environ. Contam. Toxicol. 2010;58:275-285.
  97. Young TA, Heidler J, Matos-Pérez CR, et al. Ab initio and in situ comparison of caffeine, triclosan, and triclocarban as indicators of sewage-derived microbes in surface waters. Environ. Sci. Technol. 2008;42:3335-3340.
  98. Li D, Kim M, Shim WJ, Yim UH, Oh JR, Kwon YJ. Seasonal flux of nonylphenol in Han River, Korea. Chemosphere 2004;56:1-6.
  99. Wu Z, Zhang Z, Chen S, He F, Fu G, Liang W. Nonylphenol and octylphenol in urban eutrophic lakes of the subtropical China. Fresen. Environ. Bull. 2007;16:227-234.
  100. Heberer T, Schmidt-Baumler K, Stan H. Occurrence and distribution of organic contaminants in the aquatic system in Berlin. Part I: Drug residues and other polar contaminants in Berlin surface and groundwater. Acta Hydroch. Hydrob. 1998;26:272-278.<272::AID-AHEH272>3.0.CO;2-O
  101. Collier AC. Pharmaceutical contaminants in potable water: potential concerns for pregnant women and children. EcoHealth 2007;4:164-171.
  102. Schriks M, Heringa MB, van der Kooi MM, de Voogt P, van Wezel AP. Toxicological relevance of emerging contaminants for drinking water quality. Water Res. 2010;44:461-476.
  103. WHO. World Health Organization. Guidelines for drinking-water quality. 4th ed. 2011.
  104. USEPA. United States Environmental Protection Agency. National primary drinking water regulations-maximum contaminant levels. 2011.
  105. Health Canada. Guidelines for Canadian drinking water quality-summary table. Water, air and climate change bureau, healthy environments and consumer safety branch, Ottawa, Ontario. 2012.
  106. NJMRC. National health and medical research council. Australian drinking water guidelines. 2011.
  107. EU. European Union. Water framework directive 2008/105/EC. European parliament and of the council. 2008.
  108. SCHER. Scientific Committee on Health and Environmental Risks. Chemicals and the water framework directive: draft environmental quality standards-diclofenac, ethinylestradiol, 17$\beta$-estradiol. 2011.
  109. Gibs J, Stackelberg PE, Furlong ET, Meyer M, Zaugg SD, Lippincott RL. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time. Sci. Total Environ. 2007;373:240-249.
  110. Nam SW, Jo BI, Yoon Y, Zoh KD. Occurrence and removal of selected micropollutants in a water treatment plant. Chemosphere 2014;95:156-165.
  111. Hernando MD, Heath E, Petrovic M, Barcelo D. Trace-level determination of pharmaceutical residues by LC-MS/MS in natural and treated waters. A pilot-survey study. Anal. Bioanal. Chem. 2006;385:985-991.
  112. Kolpin DW, Furlong ET, Meyer MT, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002;36:1202-1211.
  113. Brown KD, Kulis J, Thomson B, Chapman TH, Mawhinney DB. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci. Total Environ. 2006;366:772-783.
  114. Barnes KK, Kolpin DW, Furlong ET, Zaugg SD, Meyer MT, Barber LB. A national reconnaissance of pharmaceuticals and other organic wastewater contaminants in the United States-I) Groundwater. Sci. Total Environ. 2008;402:192-200.
  115. Yu Y, Huang Q, Wang Z, Zhang K, Tang C, Cui J, Feng J, Peng X. Occurrence and behavior of pharmaceuticals, steroid hormones, and endocrine-disrupting personal care products in wastewater and the recipient river water of the Pearl River Delta, South China. J. Environ. Monit. 2011;13:871-878.
  116. Behera SK, Kim HW, Oh JE, Park HS. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. Sci. Total Environ. 2011;409:4351-4360.
  117. Klecka GM, Staples CA, Clark KE, van der Hoeven N, Thomas DE, Hentges SG. Exposure analysis of bisphenol A in surface water systems in North America and Europe. Environ. Sci. Technol. 2009;43:6145-6150.
  118. Yoon Y, Ryu J, Oh J, Choi BG, Snyder SA. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea). Sci. Total Environ. 2010;408:636-643.
  119. Loos R, Locoro G, Comero S, et al. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Res. 2010;44:4115-4126.
  120. Morasch B, Bonvin F, Reiser H, et al. Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part II: Micropollutant removal between wastewater and raw drinking water. Environ. Toxicol. Chem. 2010;29:1658-1668.
  121. Kock-Schulmeyer M, Villagrasa M, Lopez de Alda M, Cespedes-Sanchez R, Ventura F, Barcelo D. Occurrence and behavior of pesticides in wastewater treatment plants and their environmental impact. Sci. Total Environ. 2013;458:466-476.
  122. Hernando M, Mezcua M, Gomez M, Malato O, Aguera A, Fernandez-Alba A. Comparative study of analytical methods involving gas chromatography-mass spectrometry after derivatization and gas chromatography-tandem mass spectrometry for the determination of selected endocrine disrupting compounds in wastewaters. J. Chromatogr. A. 2004;1047:129-135.
  123. Gomez MJ, Lacorte S, Fernandez-Alba A, Aguera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 2007;66:993-1002.
  124. Lin AYC, Tsai YT. Occurrence of pharmaceuticals in Taiwan's surface waters: Impact of waste streams from hospitals and pharmaceutical production facilities. Sci. Total Environ. 2009;407:3793-3802.
  125. Loos R, Locoro G, Contini S. Occurrence of polar organic contaminants in the dissolved water phase of the Danube River and its major tributaries using SPE-LC-MS$^2$ analysis. Water Res. 2010;44:2325-2335.
  126. Matamoros V, Arias CA, Nguyen LX, Salvadó V, Brix H. Occurrence and behavior of emerging contaminants in surface water and a restored wetland. Chemosphere 2012;88:1083-1089.
  127. Yang X, Chen F, Meng F, et al. Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China. Environ. Sci. Pollut. Res. 2013:1-12.
  128. Fram MS, Belitz K. Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking-water supply in California. Sci. Total Environ. 2011;409: 3409-3417.
  129. Kosma CI, Lambropoulou DA, Albanis TA. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010;179:804-817.
  130. Conkle JL, White JR, Metcalfe CD. Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere 2008;73: 1741-1748.
  131. Park J. An approach for developing aquatic environmental risk assessment framework for pharmaceuticals in Korea. Korea Environment Institute. 2006.
  132. Kim I, Tanaka H. Photodegradation characteristics of PPCPs in water with UV treatment. Environ. Int. 2009;35:793-802.
  133. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ. Sci. Technol. 2009;43:597-603.
  134. Bendz D, Paxeus NA, Ginn TR, Loge FJ. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazard. Mater. 2005; 122:195-204.
  135. Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 2006;40:3297-3303.
  136. Zhao JL, Ying GG, Wang L, et al. Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry. Sci. Total Environ. 2009;407:962-974.
  137. Hilton MJ, Thomas KV. Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A. 2003;1015:129-141.

Cited by

  1. Surface modified nanostructured-TiO2 thin films for removal of Congo red vol.35, pp.10, 2018,
  2. Toxicological analysis of water mixtures of organic micropollutants subjected to UV irradiation vol.44, pp.2267-1242, 2018,